The plan may include nutrition guidance, hydration targets, protein goals, activity recommendations, and strategies to reduce nausea or constipation
Wegovy follows a more gradual escalation pattern, starting at 0.25 mg and increasing monthly through 0.5 mg, 1.0 mg, 1.7 mg, to a maintenance dose of 2.4 mg weekly
These three receptor pathways form the foundation of next-generation multi-agonist therapies that deliver deeper, more sustained weight-loss and metabolic improvements than single-target drugs
During the first couple of weeks, some patients report: Better skin hydration A healthier-looking glow Calmer, more refreshed-looking skin Early improvement in overall skin texture These early changes are consistent with GHK-Cus studied role in skin support and repair